AlloVir logo
AlloVir ALVR

Annual report 2025
added 03-17-2026

report update icon

AlloVir Long Term Debt Current 2011-2026 | ALVR

Annual Long Term Debt Current AlloVir

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
316 K - 10.8 M 7.16 M 6.59 M 3.23 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
10.8 M 316 K 5.62 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Aligos Therapeutics Aligos Therapeutics
ALGS
3.58 M $ 8.64 8.07 % $ 85.4 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.66 -1.48 % $ 8.81 B australiaAustralia
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
7.93 M $ 21.36 4.86 % $ 998 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
3.55 M $ 1.47 5.0 % $ 378 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 2.92 - $ 4.81 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.19 2.7 % $ 448 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.12 -0.37 % $ 3.07 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.55 M $ 32.59 1.09 % $ 2.16 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.47 -1.34 % $ 391 M britainBritain
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 2.22 2.3 % $ 461 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
716 K $ 0.82 1.13 % $ 27.9 M israelIsrael
Baudax Bio Baudax Bio
BXRX
5.6 M - 0.59 % $ 63 K usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.2 2.24 % $ 322 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA